bepirovirsen   Click here for help

GtoPdb Ligand ID: 14707

Synonyms: GSK-3228836 | GSK-3228836B | GSK-3389404 | GSK3389404 | Hibsago® | IONIS HBVRX | ISIS-505358 | ISIS-GSK3RX
Approved drug
bepirovirsen is an approved drug
Compound class: Nucleic acid
Comment: Bepirovirsen (GSK3389404) is an antisense oligonucleotide (ASO) therapy that is proposed as a functional cure for chronic hepatitis B, by binding to hepatitis B virus RNA and preventing viral protein translation and replication. It may also mediate HBV mRNA degradation, potentially via the innate immune response initiated by its CpG motif [2]. The molecule is N-acetylgalactosamine (GalNAc)-conjugated to enhance hepatocyte delivery.

Full necletide sequence is all-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'→5')-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-P-thioadenylyl-(3'→5')-2'-deoxy-P-thioadenylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-5-methyl-P-thiocytidylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-P-thioadenylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'→5')-2'-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'→5')-2'-O-(2-methoxyethyl)-5-methylcytidine
References
1. Hou J, Lim SG, Buti M, Yuen MF, Gane E, Lampertico P, Terrault N, Nguyen H, Yim HJ, Xie Q et al.. (2026)
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.
N Engl J Med, 394 (24): 2395-2406. [PMID:42206582]
2. Vaillant A. (2023)
Bepirovirsen/GSK3389404: Antisense or TLR9 agonists?.
J Hepatol, 78 (3): e107-e108. [PMID:36116715]
3. Yuen MF, Heo J, Kumada H, Suzuki F, Suzuki Y, Xie Q, Jia J, Karino Y, Hou J, Chayama K et al.. (2022)
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy.
J Hepatol, 77 (4): 967-977. [PMID:35714812]
4. Yuen MF, Lim SG, Plesniak R, Tsuji K, Janssen HLA, Pojoga C, Gadano A, Popescu CP, Stepanova T, Asselah T et al.. (2022)
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.
N Engl J Med, 387 (21): 1957-1968. [PMID:36346079]